BSP team identifies cost savings for hospitals treating SIRS patients; results to be released at ASHP Midyear Clinical Meeting 2014


Anaheim, California: Treating systemic inflammatory response syndrome (SIRS) afflicted hospitalized patients with balanced calcium-free intravenous crystalloid solutions (solutions of mineral salts or other water-soluble molecules) can save a 300-bed hospital as much as $2.77 million over 5 years according to a budget impact model (BIM) study produced by a research team comprising of Boston Strategic Partners, Inc. (BSP) researchers: Dr. Sibyl Munson, Dr. Victor Khangulov and Dr. Scott Paluszkiewicz and researchers at Baxter Health Care: Suzanne Laplante, Director, Health Economics-Global Products and Dr. Carol R. Schermer, Medical Director, Drugs and Solutions .

The BIM results will be released at the 2014 Midyear Clinical meeting of the American Society of Health-System Pharmacists (ASHP).  The meeting will take place Dec. 7-11, in Anaheim, CA.

The costs of the currently common practice of using a 0.9% saline solution for the resuscitation of patients with (SIRS) were compared with the costs of using balanced crystalloids.  The BIM showed annual and cumulative cost savings when the balanced crystalloid solution was used. These savings were realized due to decreased complication rates.

Data for the BIM was sourced from BSP team’s analysis of the Cerner Health Facts® database which contains information about 37 million unique patients over a 14 year timeframe. Unlike many claims databases that only provide information about the tests that have been ordered, this database contains detailed lab results allowing for associations between labs and clinical outcomes to be determined.  Protected Health Information (PHI) which could specifically identify a patient (like name, address, or social security number) is not included in Cerner Health Facts®  database.

About the ASHP Midyear Clinical Meeting

The ASHP Midyear Clinical Meeting is the largest gathering of pharmacists in the world and is attended by more than 20,000 pharmacy professionals from 86 countries. The ASHP Midyear Clinical Meeting has a 40 year tradition of providing health system pharmacy practitioners with a venue to not only network with colleagues to update their knowledge, but also to keep abreast of the latest products and technologies and enhance their skills.

See more at:

About BSP

Boston Strategic Partners, Inc. is a leading global healthcare consulting firm offering services to the life sciences industry in the areas of Business and Clinical Strategy, Health Economics and Outcomes research (HEOR) and Medical & Technical Communications.

See more at: